Category: Pharmaceuticals

Pharmaceuticals

Positive Data for Co-administered Flu Vaccine and COVID-19 Vaccine

Positive results from the first co-administration study of a SARS-CoV-2 vaccine candidate and an approved influenza vaccine have been published in The Lancet Respiratory Medicine.

Pharmaceuticals

Novavax Pursuing UK Authorization for COVID-19 Vaccine

Novavax has completed its rolling regulatory submission for authorization of its NVX-CoV2373 COVID-19 vaccine candidate in the United Kingdom.

Pharmaceuticals

FDA Approves Tecentriq for Early NSC Lung Cancer

The FDA has approved atezolizumab (brand name Tecentriq, Genetech) as adjuvant treatment following surgery and platinum-based chemotherapy for adults with Stage II-IIIA non-small cell lung cancer.

Clinical Trials

Pfizer Vaccine Safe for Children Age 5-11

Administering a 10 ug dose of the Pfizer/BioNTech COVID-19 vaccine in children age 5-11 was safe and effective, according to a Phase 2/3 trial.

US Pharmaceuticals

FDA Vaccine Committee Unanimously Favors Vaccine Boosters in Americans 65+

The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend the emergency use for a booster dose of the Pfizer/BioNTech vaccine in individuals age 65 and older and individuals at high risk of severe COVID-19.

Intl' Pharmaceuticals

Clinical Trial Begins for 2nd-Gen COVID-19 Vaccine

A Phase I/II clinical trial in the Netherlands will test AKS-452, a COVID-19 vaccine candidate that is shelf-stable for at least 4 months without refrigeration.